Comparative Analysis of the Clinical Features and Long-Term Outcomes of Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration

Table 2

Long-term disease progression and treatment history of pachychoroid group and AMD group.

Category	PCN group	nAMD group	value
Number of intravitreal injection for 1 year^†	4.1 ± 0.9	4.7 ± 1.1	0.545
Number of intravitreal injection for 3 years^†	6.0 ± 1.1	7.1 ± 1.3	0.081
Number of intravitreal injection for 5 years^†	7.2 ± 1.2	9.5 ± 1.3	0.028
Treatment of PDT^‡ (eyes, (%))	15 (50%)	20 (33.3%)	0.114

Values are presented as mean ± SD, otherwise indicated. , statistically significant value; †, analyzed by paired t-test; ‡, analyzed by Fisher’s exact test.